Cytodyn Inc (CYDY)

[Saltz]

The company has been soft playing that potential for quite some time. The hope is the FDA will come to that conclusion while Nader can show respect by publicly acknowledging a Pivotal P3 for 300 patients will be needed for Mono approval.

The Covid play has not only consumed the world but CYDY’s resources and focus. It’s the only game in town right now if you have a legitimate shot. We all know what successful Covid trial results will mean to CYDY. Exposure on the big stage, uplist to the Nasdaq, a licensing/partnership deal w BP, and an abundance of financial firepower to expedite the gazillion other indications.

This is like betting all you got on a trifecta with a 90% chance of winning.